ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Research Advocates Prepare to Face Republican-led Congress

December 19, 2014

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

August 9, 1985

Breast Treatment Component Will Be Planned for WHI

June 21, 1991

Women’s Health Study To Supplant Need for WHT, Greenwald Says

May 31, 1991

In Brief: Kirsten To Join NCI As Head of FCRF, AIDS Vaccine Development Thaddeus Domanski Dies

February 5, 1988

President’s Budget: $64 Million Cut for NCI, No Start On Year 2000 goals, Drop 240 Grants In 1985

February 8, 1985